1. Advance of Mesenchymal Stem Cells in Chronic End-Stage Liver Disease Control
   Yun Gao et al, 2022, Stem Cells International CrossRef
2. The Space of Disse: The Liver Hub in Health and Disease
   Carlos Sanz-García et al, 2021, Livers CrossRef
3. Matrix Metalloproteinases as Potential Biomarkers and Therapeutic Targets in Liver Diseases
   Eline Geervliet et al, 2020, Cells CrossRef
4. Progress of Interference of Traditional Chinese Medicine on Cirrhosis Treated with Bone Marrow Mesenchymal Stem Cells
   Yaxin Wang et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
5. Molecular Pathways Modulated by Mesenchymal Stromal Cells and Their Extracellular Vesicles in Experimental Models of Liver Fibrosis
   Giulia Chiabotto et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
6. Therapeutic efficiency of bone marrow-derived mesenchymal stem cells for liver fibrosis: A systematic review of in vivo studies
   Zaid Al-Dhamin et al, 2020, World Journal of Gastroenterology CrossRef
7. The aryl hydrocarbon receptor pathway controls matrix metalloproteinase-1 and collagen levels in human orbital fibroblasts
   Elisa Roztocil et al, 2020, Scientific Reports CrossRef